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ARTICLE
A framework for identifying the recent origins
of mobile antibiotic resistance genes
Stefan Ebmeyer1,2, Erik Kristiansson1,3 & D. G. Joakim Larsson 1,2✉
Since the introduction of antibiotics as therapeutic agents, many bacterial pathogens have
developed resistance to antibiotics. Mobile resistance genes, acquired through horizontal
gene transfer, play an important role in this process. Understanding from which bacterial taxa
these genes were mobilized, and whether their origin taxa share common traits, is critical for
predicting which environments and conditions contribute to the emergence of novel resis-
tance genes. This knowledge may prove valuable for limiting or delaying future transfer of
novel resistance genes into pathogens. The literature on the origins of mobile resistance
genes is scattered and based on evidence of variable quality. Here, we summarize, amend and
scrutinize the evidence for 37 proposed origins of mobile resistance genes. Using state-of-
the-art genomic analyses, we supplement and evaluate the evidence based on well-defined
criteria. Nineteen percent of reported origins did not fulfill the criteria to confidently assign
the respective origin. Of the curated origin taxa, >90% have been associated with infection in
humans or domestic animals, some taxa being the origin of several different resistance genes.
The clinical emergence of these resistance genes appears to be a consequence of antibiotic
selection pressure on taxa that are permanently or transiently associated with the human/
domestic animal microbiome.
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Antibiotic resistance has become a major threat to thefundaments of modern medicine during the last decades.Resistance genes have emerged against almost all classes
of antibiotics, even against those considered last resort. Mobile
antibiotic resistance genes (ARGs) are associated with a variety
of mobile genetic elements (MGEs) that enable these genes to
spread to new hosts, even across taxonomic boundaries. Insertion
sequences (ISs)1,2 and IS common region (ISCR) elements3–5
have been shown to provide both mobility and strong promotors
for the expression of ARGs. In several cases, these are key ele-
ments for the mobilization of ARGs from a bacterial chromosome
to transferable MGE, such as plasmids or conjugative transpo-
sons6–8. Although novel ARGs frequently are reported, their
origins, meaning the bacterial taxa from which these genes were
mobilized, facilitating their transfer to clinically relevant mobile
vectors, are unknown for the largest part. Understanding where
ARGs come from and which environments, conditions, and/or
human practices favor their emergence is necessary to effectively
mitigate the emergence of still unknown ARGs in the clinics. Such
knowledge will, however, likely be of limited use for managing the
ARGs that are already found in the clinics, as it has been shown
that once emerged, ARGs are maintained in parts of a population
for a long time even in absence of selection pressure, making their
emergence practically irreversible9,10.
Predicting the conditions that are likely to favor the emergence
of new ARGs based on the known origins of single or a few ARGs
is difficult. However, identifying the origins of a greater number
of ARGs may enable us to recognize underlying patterns, such as
shared characteristics of origin species, how ARGs are mobilized
from their most recent non-mobile origin, the environments they
thrive in or their connections to human- or animal associated
bacteria. A strong hypothesis is that selection pressure from
antibiotic use in humans and domestic animals has played a
critical role in their emergence11,12. As the environmental reser-
voir of ARGs is much greater than what is identified in the
human and domestic animal microbiota, it is possible that other
environments, as well as anthropogenic selection pressures in
those environments, play a critical role in this development
too13,14. Although the origins of some mobile ARGs have been
reported and extensive reviews exist on the origin and dis-
semination of specific groups of clinically problematic ARGs such
as mobile AmpC enzymes15,16 or CTX-M family β-lactamases17,
there is no summary or analysis of all proposed ARG origins to
date. Furthermore, the types and quality of evidence presented to
identify those origins vary substantially, from mostly molecular
methods to (more recently) purely sequencing-based approaches.
This creates the need to carefully evaluate each reported ARG
origin based on a fixed set of criteria, to ensure the integrity of our
knowledge about ARG origins and guide future efforts to identify
these.
In this study, we establish a set of comparative criteria that can
be used to identify the origins of mobile ARGs on at least genus
level with high confidence, based on patterns recognized from
thorough literature research. We evaluate the evidence on each
previously reported origin based on these criteria and supplement
missing data (if available) through amendment with publicly
available genome data and state-of-the-art comparative genomics
analysis. Finally, we analyze the existing data and discuss what we
can conclude from the curated list of origins with regards to
overarching patterns on origin species traits and taxonomy, as
well as mode of ARG mobilization from their origin and potential
circumstances favoring their emergence in human pathogens.
Scrutinizing previous reports, we find that only 81% of sug-
gested origins are supported by the data. We show that all con-
firmed origin taxa are Proteobacteria, several species being the
origin of several ARGs and almost all associated with infection in
humans or domestic animals. These results highlight the potential
importance of the human/animal body as mobilization hotspots
for ARGs. Still, the lack of known origins for the great majority
of ARGs points towards unsequenced environmental bacteria as
likely sources.
Results
Our literature search yielded 3342 articles. After screening of all
hits (including the references of articles deemed relevant), 43
articles providing evidence for genus or species origins of an ARG
were retained for further analysis, which is illustrated in Fig. 1.
Definition of origin. For mobile ARGs found in pathogens, we
use the term recent origin, describing the bacterium belonging to
the evolutionary most recent taxon where the ARG is widespread,
Fig. 1 Comparative genomics workflow. Workflow and tools/databases used for amendment and scrutinization of proposed origins of ARGs.
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but commonly not associated with (any of) the MGE(s) (e.g., IS,
integron, transposon, plasmid, or as part of an integron) that
played a role in the ARGs transition to its clinically relevant
contexts. Thus, recent origin does not encompass the evolu-
tionary processes that shaped the genes functionality, whether
ancient18 or recent17, nor ancient transfers across taxa involving
different mechanisms. This distinction is important, because
there is evidence that the recent origins of some genes may not
necessarily be the taxonomic context in which the respective gene
originally evolved. For guiding mitigations, however, it is most
important to understand from which bacteria ARGs have been
mobilized prior to being transferred to pathogens, processes
where anthropogenic activities could have played a role. The
mobile qnrB gene, e.g., shown to have been mobilized to clinically
important plasmids from the chromosome of Citrobacter spp., is
found in several but not all species of the genus. Yet, their genetic
environment is very similar in all species harboring the gene on
their chromosome19. Similar findings have been reported for
PER-type8 and qnrE20 genes. This suggests that certain lineages of
these genera may have acquired the respective genes at some
point during their more ancient evolution, before they were
mobilized to the MGEs that we observe in clinical isolates today
(see Fig. 2).
Formulation of evaluation criteria. By scrutinizing previously
proposed origins and thorough reflection on the strength of
different lines of evidence, we formulated the following criteria to
identify the recent origin of an ARG (Fig. 3):
● The mobile ARG is associated with a recognizable genetic
element that may provide mobility, such as a plasmid,
transposon, IS, or ISCR element.
● In the proposed origin taxon, the ARG is found in a
genetic context that does not appear transferable by
common mechanisms, such as association with plasmids,
transposons, etc.
● There is conserved synteny (the genes in the intermediate
vicinity of the ARG are arranged in the same/similar order)
between the origin chromosome and the mobile ARG locus
(due to co-mobilized genes). This criterion excludes genes
potentially providing mobility (such as IS) and is rarely
applicable for gene cassettes, as usually no surrounding
genes are co-mobilized.
● There is high nucleotide identity between the mobile
ARG, including the complete mobilized sequence, and
the native ARG locus (the higher identity, the stronger the
evidence). For confident recent origin genus or species
Fig. 2 The principle of recent origins. Schematic phylogeny illustrating the principle of recent origins of ARGs. Blue arrows represent horizontal gene
transfer events (HGT); red circle on node represents an ARG progenitor. Changing color of circle represents sequence evolution over time. Two possible
scenarios are shown: ARG A evolves in the same taxonomic clade as the ARG progenitor prior to being transferred to a pathogen. In case of ARG B, the
ARG progenitor is acquired through an ancient HGT event before it is, more recently, transferred to pathogens, and is thus not present in the sister clades
of the recent origin of ARG B. In both cases, the recent origin is the taxon from which the gene is mobilized into clinically relevant contexts.
Fig. 3 Assigning the recent origin of an ARG. Graphical representation of strong evidence for assigning the recent origin of an ARG using the evaluation
criteria described above.
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assignment, nucleotide identities we used ≥90% and ≥95%,
respectively.
● The synteny of the ARG locus is to some extent conserved in
several species of the origin genus, but the ARG loci are not
identical with respect to nucleotide identity.
It is noteworthy that functionality—the ability of a gene to
provide resistance—is not part of the criteria, as it is a blunt tool
compared to sequence-based analysis. Indeed, several ARGs have
been shown not to confer resistance in their original host under the
investigated conditions21,22.
The majority of confirmed origins are pathogenic non-
producers. We have scrutinized the evidence on the origin of 37
groups of ARGs, which, to the best of our knowledge, summarizes
the current literature on specific origins of ARGs. For each ARG
group, a detailed description and discussion on the evidence or lack
thereof for its proposed origin is provided in supplementary note 1.
Based on the criteria set up here, 30 (81%) of the proposed origins
could be confirmed for the respective ARG group, though we had to
supplement data from our own analysis for most to fulfill all cri-
teria. In seven cases (19%), the criteria were not sufficiently fulfilled
to confidently assign an origin (MCR-4, MCR-9, MCR-8, MCR-3,
KPC, QnrS, and TetX detailed information in Table 1 and Sup-
plementary Note 1 under the respective paragraph). Further data
would be needed to confirm or correct the reported origins of those
resistance genes. An increase in the taxonomic resolution of one of
the reports through our analysis identified the recent origin of qnrE
as Enterobacter mori, where previously only an origin in Enter-
obacter spp. was reported (see Supplementary Note 1—qnrE from
Enterobacter spp.). The origins of 27 groups of ARGs could be
confirmed on species level, resulting in 22 species groups, all of
those being Proteobacteria. None of the here reported recent origins
are known antibiotic producers (although this was expected for, e.g.,
the origins of qnr genes, as fluoroquinolones are synthetic anti-
biotics not produced in nature). The respective mobilized genes
encode resistance to five different classes of antibiotics: aminogly-
cosides (6.8%), β-lactams (62%), fluoroquinolones (13.7%), fosfo-
mycin (13.7%), and colistin (3.4%) (see Table 1).
Interestingly, nearly all origin species have previously been
associated with humans and/or domestic animals. Out of 22
origins identified at species level, 21 (95%) have been isolated
from humans or domestic animals, the exception being
Rheinheimera pacifica, the likely origin species of LMB-1. For
comparison, out of 100 randomly selected proteobacterial
species with available genomes, 28 species have been isolated
from humans or domestic animals, whereas 72 were not
(Fisher’s exact test odds ratio: 54.0, p= 3.08e− 9).
More strikingly, all of these origin taxa (except R. pacifica) have
been isolated from infection sites. For comparison, out of the 100
randomly selected proteobacterial species, 24 species have been
isolated from infection sites, whereas 76 have not (Fig. 4). Based
on this subsample of proteobacterial species, Fisher’s exact test
showed that the odds of being an origin were higher for species
that have been reported in infection compared to species that
never have been reported in infection (Fisher’s exact test odds
ratio: 66.5, p= 3.13e− 10).
More ARGs are associated with transposable non-integron
elements than with integrons. None of the genes for which ori-
gins have been confirmed is a gene cassette and the evidence sug-
gests in most cases that the genes have been moved from their
original context by IS or ISCR elements. Our analysis of associations
of ARGs with different modes of mobility (gene cassette vs. trans-
posable unit (excluding mobile integrons)-associated) resulted in
144 different genes belonging to 63 protein families being classified
as gene cassettes, whereas 512 genes from 264 families were clas-
sified as associated with transposons. Although we can identify gene
cassettes from clinically relevant integron classes with relatively high
confidence, the estimate on transposon-borne ARGs is much more
speculative, as it is difficult to say whether the respective IS/ISCR/
transposon truly provides mobility to the respective ARG, or
whether it is just present in close vicinity due to the highly mosaic
nature of many ARG-bearing MGEs.
Discussion
The criteria proposed in this study for identifying the origins of a
mobile ARG are a reflection of what we found in the literature—
many studies describing the recent origins of mobile ARGs paint a
consistent picture: the mobile ARG is usually associated with a
genetic element providing mobility, whereas such an element is not
present at the presumed non-mobile ARG locus. In nearly all cases,
one or several genes from the non-mobile genetic environment of the
ARG have been co-mobilized to the mobile ARG locus and the
nucleotide identity between the non-mobile and the mobile ARG
locus is high, including non-coding regions. The identity cutoffs for
genus/species origins specified in criterion 4 are based on the
observations made in this study (see Table 1). The presence of the
gene locus (although somewhat divergent) in closely related species
helps to establish whether the locus has been associated with
the respective species chromosome for some time. The majority of
the criteria apply in all cases where there is strong evidence for the
origins of an ARG—which is why we propose it should be a standard
procedure to check for these criteria when investigating a species as
origin of an ARG. It should however be noted that in some cases not
all criteria would have to be fulfilled to assign an origin—a gene
cassette for example will rarely be associated with co-mobilized genes.
All of the to date, with high confidence, identified origin spe-
cies are Gram-negative Proteobacteria and have been, with
the exception of one species, reported in infections of humans
and/or domestic animals. Many of these species are well-studied
human and animal pathogens or commensals, such as Citrobacter
freundii, Klebsiella pneumoniae, or Acinetobacter baumanii. Even
more intriguing is that many species/genera are the origin of not a
single, but often several different ARG families. K. pneumoniae is,
e.g., not only the recent origin of SHV-type β-lactamases23 but
also of the mobile oqxAB efflux pump24 and the fosA5/6 fosfo-
mycin resistance genes. Kluyvera georgiana is the recent origin of
both the CTX-M-8/9 cluster of class A β-lactamases25 and the
fosfomycin resistance genes fosA3/426, whereas the C. freundii
complex is the recent origin of the qnrB19 and CMY-227 family
genes. Our analysis suggests that a proteobacterial species is much
more likely to be the origin of an ARG if it has been isolated from
an infection site in humans or domesticated animals. The over-
representation analysis shows that this finding is not simply a
product of database bias towards pathogenic species, as the great
majority of randomly sampled proteobacterial species in the
NCBI Assembly database have not been reported in infection.
Although this does not at all exclude the possibility of other
environmental bacteria (meaning species more often associated
with external environments) serving as origin species, this data
strongly suggests that the potential of a bacterial species to be a
recent origin of an ARG is linked to its ability to colonize humans
or domesticated animals, at least for proteobacterial species. In
these environments, those species may experience severe anti-
biotic selection pressure and at the same time encounter MGEs
that have mobilized ARGs in the past. As previously mentioned,
there is also convincing evidence that in many cases different
variants of the same ARG family have emerged independently from
one another, as opposed to being the result of post-mobilization
evolution. This includes the CMY-1/MOX-1 AmpC enzymes from
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Aeromonas spp.28, the PER ESBLs from Pararheinheimera spp.8
(Fig. 5, blaPER-6 locus as reported by Nordmann et al.29), the SHV
and FosA5/6 genes from K. pneumoniae23, the ACT/MIR AmpC
cephalosporinases from Enterobacter cloacae/asburiae30,31, qnrB
from Citrobacter spp., different variants of OXA-51-like genes from
Acinetobacter baumannii32,33, CTX-M enzymes from Kluyvera
spp.17, and more with variable levels of evidence. This further
supports the hypothesis that these recent origin species can thrive in
habitats repeatedly exposed to strong antibiotic selection pressure
by different classes of antibiotics, such as the human/domesticated
animal microbiome. A limitation for making broader general-
izations is that most of the origins described here relate to genes
that confer resistance to β-lactams. Thus, the patterns described
here may or may not reflect genes providing resistance to other
antibiotic classes, where no origin is known, to the best of our
knowledge (e.g., tetracyclines or macrolides). Thus, identifying their
origin using this set of criteria may not be possible. Importantly, the
NCBI Assembly database is biased towards proteobacteria—it is
entirely possible that in the future, as the diversity of available
genomes increases, non-proteobacterial, non-infection-associated
recent origins of ARGs are identified. Indeed, there is some evi-
dence for the dissemination of clinically relevant ARGs from
Actinobacteria to Proteobacteria34. However, to date reported
sequence similarities between non-mobile actinobacterial genes and
proteobacterial ARGs are too low (<70% amino acid identity) to
draw any conclusion about Actinobacteria as recent origins of these
genes—possibly due to lack of the relevant actinobacterial genomes.
There are several factors that have to come together for the
successful emergence of a mobilizable ARG: in addition to suffi-
ciently strong antibiotic selection pressure, MGEs with the potential
to mobilize genes, such as IS/ISCR, also have to be present, as well
as compatible recipients for the newly mobilized ARG. The simplest
setting where all of these factors come together is the human/animal
body during antibiotic treatment. The human/animal microbiome
likely already contains many IS/ISCR elements that have been
suspected to be involved in ARG mobilization35,36 and the con-
stituents of these microbiomes engage intensively in horizontal gene
transfer37,38, especially under stress. Some of the species reported to
be recent origins of ARGs are members of the human microbiome,
such as Enterobacter, Klebsiella, Citrobacter, or Acinetobacter39.
Others are opportunistic pathogens that are known to at least pass
the human/animal body, sometimes causing infection and thus
directly triggering antibiotic use, such as Aeromonas spp. Other
genera, such as Rheinheimera and Pararheineheimera have not yet
been reported to be part of the human/domestic animal micro-
biome or to be involved in disease. However, as both genera can be
found in water (both fresh and saline), it is still possible that these
bacteria may pass the human/animal body through ingestion of
contaminated water. Although it is certainly possible for a novel
ARG to be mobilized in the external environment and be trans-
ferred to human pathogens later, this scenario involves more steps
and may therefore be less likely, especially if strong antibiotic
selection pressure is required for the emergence process. Capture of
ARGs from bacteria that are temporarily passing through the body
might be possible, given that we know the recent origins of only a
small percentage of all known ARGs. We mostly know these ori-
gins, because many of the species have at least some clinical rele-
vance and our efforts to characterize (and in the last decade,
sequence) have been biased heavily towards bacteria frequently
causing disease. Possibly, the great majority of ARG origins is
unknown, because they are not permanently associated with the
human/animal body, rarely or never cause disease and have
Fig. 4 Association with infection for randomly selected Proteobacteria
and origin species. Grouped barchart showing number of species reported in
infection for origin and non-origin species (n= 122). Non-origin species were
randomly selected from all proteobacterial species in the NCBI Assembly
database. Fisher’s exact test odds ratio: 66.5, p= 3.13e− 10.
Fig. 5 Multiple mobilization events of an ARG may result in association with different mobile contexts. Multiple contexts for ARGs of the same family as
a consequence of multiple independent mobilization events on the example of blaPER ESBLs, mobilized from Pararheinheimera spp. Elliptic shapes (grossly)
represent the areas from which different blaPER variants have been reported. Although blaPER-2 and blaPER-1 are both associated with ISPa12, the blaPER loci
(including blaPER and co-mobilized genes) on the depicted MGEs are about 20% dissimilar in nucleotide identities. blaPER-6 is 13% dissimilar to blaPER-2 and
about 20% dissimilar to blaPER-1. Transposable elements are presented with dotted pattern and blaPER genes with striped pattern.
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therefore not been investigated extensively (or are completely
unknown to science yet). The ResFinder database contains 3095
unique ARGs up to date (September 2019), corresponding to 696
gene clusters when clustered at 90% nucleotide similarity. Based on
this and the origins described here, we currently know the origin of
only about 4% of described acquired resistance genes. For some
classes of ARGs, such as tetracyclines or macrolides, no species
origin is known at all, despite tetracyclines being one of the most
extensively used antibiotics in, e.g., agriculture40. This suggests that
many ARG origins thrive in other environments, such as water, soil,
or associated with plants, underlining that the natural environment
may act as a source of novel resistance determinants41,42 (as sup-
ported by, e.g., functional metagenomics studies identifying many
novel ARGs from soil, see Forsberg et al.43). Such environmental
species may pass through the body from time to time by exposure
to contaminated matter, where their genome, especially under
antibiotic selection pressure, may be infiltrated by MGEs from the
hosts microbiome, such as plasmids, IS/ISCRs, transposons, or
integrons. However, even for described origin genera/species such
as Kluyvera spp, Pararheinheimera spp, and Aeromonas spp,
knowledge on where exactly these bacteria thrive is lacking and
further research is needed on the topic. Another explanation for the
lack of origin species for some classes of ARGs may be that they
have been mobilized a long time ago, so their origin has evolved and
cannot be identified anymore. Verifying this hypothesis, however,
requires more genomic data than available to date, especially
from bacteria not associated with the human or domestic animal
microbiome.
The accumulation of ARGs in human-associated bacteria may
also have implications for the emergence of novel ARGs in human
pathogens. As many of the ARGs are associated with IS/ISCR ele-
ments, the number of these MGEs at selection sites, e.g., the human/
animal body, also increases. This may result in an increased
potential of the respective microbiome to capture rare genes (e.g.,
from bacteria that are only temporarily associated with those
microbiomes), which can help to respond to local selection pres-
sures, using highly effective capturing machineries, such as ISCR1,
IS26, or ISEcp1. This is especially true for IS26, as it has been shown
that IS26 and co-mobilized sequences target sites associated with
other IS26 for integration44, or ISCR1, which couples newly
mobilized ARGs with class I integrons. Thus, increased acquisition
of resistance genes in a microbial community may also increase the
potential to capture novel ARGs.
Antibiotic selection pressure is likely a key factor during ARG
mobilization in many cases. The high nucleotide identities of
ARG loci towards the chromosomal loci of their origins, as
summarized in this study, suggest that all here described
mobilization events have happened relatively recently, quite
plausibly during the antibiotic era and driven by human-
imposed antibiotic selection pressure45,46. In most cases, up- or
downstream sequences from the ARGs original context have
been co-mobilized with the ARG and they are highly identical in
nucleotide sequence to their chromosomal counterparts, but we
observe that these co-mobilized sequences are often truncated
and thus likely non-functional. If the mobilization of these ARG
loci to MGEs were ancient events, higher sequence dissimilarity
to their non-mobile counterparts would be expected, if they
were preserved at all. Although it has been hypothesized that
some ARGs have been on plasmids for millions of years46 and
evolved there, thus potentially lacking a recent origin, the data
presented here strongly support that at least some ARGs have a
recent chromosomal origin. However, this does not exclude the
possibility that these genes have been plasmid-borne at some
previous time point during their evolution (see Fig. 2).
Our association analysis indicates that, of the mobile resistance
genes found in all to data available genomic assemblies, about
four times as many ARG families (at 80% sequence similarity) are
associated with transposases, IS, or ISCR compared to ARG
families that are integron-borne gene cassettes. Although the
estimate on transposon/IS/ISCR association is somewhat gross,
this finding still underlines that transposable elements including
ISs may be the main disseminating agents of mobile ARGs
between different replicons. The summarized literature on ARG
origins (Supplementary Note 1, Supplementary References) pro-
vides insights as to why it may be like that and it is also as
discussed below.
It has been shown that several ARGs do not confer clinical level
resistance in their native context. This renders some of the
above described origin species susceptible to the respective
antibiotic21,22,47,48, even though they encode a potential resistance
gene on their chromosome. Only after increased expression of the
respective gene or a transfer of the potential ARG to a multi copy
vector, which effectively increases gene dosage, does the gene induce
a clinically relevant resistance phenotype. As described in detail in
Supplementary Note 1, most of the ARGs with known origins were
likely mobilized from their native context by IS or ISCR elements.
The ability of those types of MGEs to transpose not only themselves
but also adjacent DNA sequences, upon transposition via different
mechanisms, has been demonstrated for different types of IS.
Especially ISCR1, ISEcp1, and IS26 are associated with different
ARGs and large parts of their native context in clinical
isolates8,28,49. Although it has not been experimentally validated to
date, that ISCR1 moves and mobilizes adjacent genes, its frequent
association with different ARGs and parts of their native context
provides evidence for this hypothesis. As with ISCR1, many other
IS/ISCR are also known to increase the expression of adjacent genes
through providing a promoter sequence, the creation of hybrid
promoters upon insertion or the disruption of regulatory genes at
the target site4,50. IS/ISCR induced high expression of a native ARG
may provide the host with increased resistance to the respective
antibiotic selection pressure2,3 (e.g., during antibiotic treatment),
such that the combination of IS/ISCR and ARG is selected for
under these circumstances51. The genetic context of mobilized
ARGs support this notion, as we observe that in many cases the
ARG is located directly adjacent of the IS/ISCR and thus in reach of
the respective promoters. Thus, selection leads to a frequency
increase of this gene combination in the local origin population,
increasing the likelihood that it will be mobilized to a transferrable
MGE, such as a conjugative transposon or plasmid.
In this study, we summarize, scrutinize, and supplement the
current knowledge on the origins of mobile ARGs. The here defined
set of criteria enables the identification of ARG origin species with
high confidence. All origins identified up to date are Proteobacteria
and the great majority have been associated with infection in
humans or domestic animals, hence triggering antibiotic use. Most
ARG families for which an origin has been identified consist of
several variants. In many cases, these are likely the product of
multiple, independent mobilization events, as they are associated
with different remnants of their native contexts or different mobi-
lizing agents, such as IS or ISCR elements. The most likely envir-
onment in which these genes have emerged is the human/animal
body subjected to antibiotic treatment, as it fulfills all criteria needed
for ARG emergence, especially the one of strong antibiotic selection
pressure during the entire process. That said, it is certainly possible
that other ARGs have emerged from other environments, via dif-
ferent routes, as most ARG origins are still unknown. Further
research is thus needed to show to what extent different environ-
ments and conditions contribute to ARG emergence. This includes
increased whole-genome sequencing efforts of many more bacterial
taxa. As genes whose native function may not primarily be asso-
ciated with antibiotic resistance can become ARGs under the right
conditions, the bacterial pan-genome very likely contains an
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enormous number of ARGs that have not (yet) been observed in
the clinics. Exploring the origins of ARGs further can provide us
with important insights as to where our mitigation efforts may be
most effective, to slow down the emergence of novel ARGs in the
clinics.
Methods
Literature research. A thorough literature research was conducted using the
PubMed database (using the key words “origin,” “antibiotic,” and “resistance
gene”). Hits were screened (by title and abstract) to identify articles claiming to
have identified the origins of ARGs on at least genus level and references of
identified articles were used to identify further articles of the same type. The
evidence presented for the respective origin of an ARG was summarized (see
Supplementary Note 1) and a set of criteria for identifying the origin of an ARG
with high confidence was assembled (see Results).
Furthermore, for every ARG that had a reported origin, we described how the
putative origin was identified, which MGEs, the respective ARG, has been found to
be associated with. For validated origin taxa, we also briefly described known
habitats of the respective origin genus/species and whether it has been reported in
infection in humans or domestic animals (Supplementary Table 1).
Evaluating the criteria: comparative genomics analysis. An in-house pipeline
was used to supplement the analysis in the original study with available genomic data,
if available. Based on the original data and our comparative genomics analysis, we
then evaluate if or to what extent the original report has fulfilled the five criteria for
assigning an origin. The pipeline was written in python 3.7 and is described in the
following paragraphs.
Available assemblies of bacterial genomes and plasmids were downloaded from
the NCBI Assembly database52 (April 2020). To create a well-annotated ARG
reference database containing only acquired ARGs, sequences from CARDs53
protein homolog model (v3.0.5, downloaded September 2019, recently
characterized ARGs LMB-1, FosA8, FosL, and GPC-1 were manually added) was
mapped against the Resfinder database54 (downloaded September 2019) using
DIAMOND at a 99% identity threshold and a 90% query coverage cutoff. Using the
resulting database, all genomes and plasmids were searched for the ARGs using
DIAMOND blastx v0.9.24.125 with a 70% identity cutoff and an 80% query
coverage cutoff. This relaxed cutoff was used to also identify potentially related
genes in other taxa. For those genes for which an origin was reported, up to 10 kbp
(if available) were extracted upstream and downstream of each thus identified ARG
and annotated using Prodigal v2.6.355. To identify potential functions of open
reading frames (ORFs) in the identified ARGs genetic environment, identified
ORFs were also searched against the Uniprot knowledge base (downloaded January
2019, hypothetical proteins were removed) using DIAMOND with a 60% identity
cutoff. To reduce the number of uninformative sequences (with regards to
mobility/non-mobility) for further analysis, sequences containing fewer than 6
predicted ORFs were excluded. Genes close to identified ARGs that were annotated
as transposases or IS were manually searched against the ISFinder database to
confirm their identity towards known IS elements. IntegronFinder v256 was used to
predict integrons or integron associated elements, such as attC sites, on the
artificial ARG contigs. To obtain an overall estimate of the proportion of ARGs that
are either gene cassettes (present in integron classes I–III) or mobile through IS/
ISCR or other transposons (although the estimate is much more gross for this
group than for gene cassettes), genes were placed in one of the groups using the
following criteria: ARGs were counted as gene cassettes if they were positioned
within the boundaries of a predicted complete intergron, had an attC site encoded
within at maxiumum 200 bp (accounting for an attC site length of 55–141 nt and a
spacer length of maximum 145 bp between gene cassette and attC site) downstream
of the predicted ORF, and were oriented in the opposite direction of the integrase
encoding gene. If the ARG was positioned in an incomplete integron (CALIN), an
attC site both upstream and downstream (at maximum 200 bp distance within
either side of the ORF) of the ARG were required to count it as gene cassette. An
ARG was counted as associated with a transposase if the next ORF upstream or
downstream of the gene was an IS/ISCR or other transposition element and the
gene had not previously been classified as a gene cassette.
To reduce the number of sequences to visualize, duplicates were removed. The
remaining extracted sequences were then clustered at a 95% nucleotide identity
threshold using USEARCH v8.0.144557. The resulting centroids were aligned using
MAFFT v7.31058 and a phylogenetic tree was created using FastTree v2.1.959 (gtr
model, default CAT approximation). The Python ete3 package was used to
schematically visualize each sequence associated with a node in the previously created
phylogeny, allowing for careful visual comparison of the genomic contexts of each
gene. Nucleotide or amino acid comparisons between different sequences were
conducted using NCBIs online available blast suite.
Overrepresentation analysis. To investigate whether bacterial species with the
potential to colonize humans or domestic animals were overrepresented among
species that are recent origins of ARGs, we used Fisher’s exact test. As the set of
origin species identified down to species level contained only proteobacterial
species (n= 22, each species only counted once even if it is the origin of several
ARGs), we randomly selected 100 proteobacterial species (excluding origin
species) from the NCBI Assembly database. Taxonomy information was
downloaded from the NCBI Taxonomy database. A literature search was then
performed for all 122 species names against PubMed and Google Scholar, once
on its own and again in combination with the term “infect.” Hits were screened
for information on whether there were reports of isolation of the species from
infection sites in humans or domesticated animals (see Supplementary Table 1).
A contingency table summarizing the counts was created and analyzed using
Fisher’s exact test from Pythons scipy library.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All genomes used in this study are publicly available at https://www.ncbi.nlm.nih.gov/
assembly. The synteny figures used as a first visualization of ARG loci in different
genomes are available at https://figshare.com/articles/figure/ARG_syntenies/13084553.
Code availability
The code used in this manuscript is available at https://github.com/EbmeyerSt/
ARG_loci_comparative_pipeline.
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